Innate Pharma S.A.

Innate Pharma S.A. is a biopharmaceutical company focused on discovering and developing therapeutic antibodies for the treatment of oncology. Key to its portfolio are innovative monoclonal antibodies that engage the immune system's natural ability to combat cancer, positioning the company's products at the forefront of immunotherapy. A major aspect of Innate Pharma's work revolves around harnessing Natural Killer (NK) cells and exploiting multiple mechanisms for tumor cell recognition and eradication. The company's pipeline includes various drug candidates at different phases of clinical trials, targeting both hematologic and solid tumors. Headquartered in Marseille, France, Innate Pharma collaborates with leading pharmaceutical giants to advance its research and maximize therapeutic efficiency. It plays a significant role in the biotechnology industry, contributing to advancements in cancer treatment strategies, offering novel approaches that potentially improve patient outcomes by enhancing the body’s immune response to malignancies.